Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Arthrogen B.V.

Arthrogen B.V.

Arthrogen B.V. was acquired by MeiraGTx, a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
Robert Jan Lamers
Robert Jan Lamers
Legal Name
Arthrogen B.V.
Company Operating Status
Closed
Country
Netherlands
Netherlands
Crunchbase URL
crunchbase.com/organiz...ogen-b-v
Facebook URL
@MeiraGTx
Founded Date
2015
0
Full Address
92 Brittania Walk , London/New York, N17NQ, GB
Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Biotechnology
Biotechnology
Biology
Biology
Biopharma
Biopharma
Technology
Technology
Investors
UvA Ventures Holding
UvA Ventures Holding
Latest Funding Round Date
November 2005
Latest Funding Type
Seed
Seed
Legal classification
Private limited company
Private limited company
LinkedIn URL
@company/meiragtx
Location
London
London
United Kingdom
United Kingdom
New York City
New York City
Number of Employees (Ranges)
51 – 200
Pitchbook URL
pitchbook.com/profiles...233761-87
Twitter URL
@arthrogenpharma
Official Website
arthrogen.nl/en
arthrogen.nl

Find more companies like Arthrogen B.V.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.